HomeCompareABBV vs MRK

ABBV vs MRK: Dividend Comparison 2026

ABBV yields 3.67% · MRK yields 3.25% · See full DRIP projection below

vsEnter any two US tickers
After 10 years · $10,000 invested · DRIP enabled
🏆 ABBV wins by $9.2K in total portfolio value
10 years
ABBV
AbbVie Inc.
3.67%
Share price
$168.90
Annual div
$6.20
5Y div CAGR
8.9%
Payout ratio
58%
After 10 yrs · $10,000 · DRIP
Portfolio value
$39.9K
Annual income
$1,154.43
Full ABBV calculator →
MRK
Merck & Co. Inc.
3.25%
Share price
$94.80
Annual div
$3.08
5Y div CAGR
8.2%
Payout ratio
42%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$950.29
Full MRK calculator →

Portfolio growth — ABBV vs MRK

Annual dividend income

MetricABBVMRK
Forward yield3.67%3.25%
Annual dividend / share$6.20$3.08
Payout ratio58%42%
1-year div growth4.7%5.5%
5-year div CAGR8.9%8.2%
Portfolio after 10y$39.9K$30.7K
Annual income after 10y$1,154.43$950.29
Total dividends collected$7.2K$6.1K
Payment frequencyquarterlyquarterly
SectorHealthcareHealthcare

Year-by-year: ABBV vs MRK ($10,000, DRIP)

YearABBV PortfolioABBV Income/yrMRK PortfolioMRK Income/yrGap
1$11,520$399.75$11,192$351.54+$328.00ABBV
2$13,261$450.98$12,524$392.70+$737.00ABBV
3$15,255$508.41$14,015$438.65+$1.2KABBV
4$17,536$572.74$15,682$489.96+$1.9KABBV
5$20,145$644.78$17,547$547.23+$2.6KABBV
6$23,126$725.38$19,632$611.16+$3.5KABBV
7$26,532$815.52$21,963$682.53+$4.6KABBV
8$30,420$916.26$24,571$762.18+$5.8KABBV
9$34,855$1,028.80$27,486$851.08+$7.4KABBV
10$39,914$1,154.43$30,745$950.29+$9.2KABBV

ABBV vs MRK: Complete Analysis 2026

ABBVHealthcare

AbbVie is a pharmaceutical giant best known for Humira and newer blockbusters Skyrizi and Rinvoq. A Dividend Aristocrat with 52+ years of consecutive dividend increases. Strong free cash flow generation supports its above-average yield. The company's diversified pipeline reduces dependence on any single drug.

Full ABBV Calculator →

MRKHealthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →

Frequently Asked Questions

Is ABBV or MRK better for dividend income in 2026?
ABBV currently offers a 3.67% yield (6.20/share/year) while MRK offers 3.25% (3.08/share/year). ABBV provides higher current income. However, ABBV has grown its dividend faster (8.9% 5Y CAGR), which may lead to better long-term income through compounding.
How much would $10,000 in ABBV vs MRK earn per year?
With $10,000 invested today: ABBV pays approximately $367/year. MRK pays approximately $325/year. With DRIP reinvestment over 10 years, these grow to $1,154/year (ABBV) and $950/year (MRK).
Does ABBV or MRK pay monthly dividends?
ABBV pays quarterly dividends. MRK pays quarterly dividends. Neither pay monthly — both use a quarterly schedule, which is preferred by investors who need regular cash flow.
📬

Get this ABBV vs MRK comparison by email

Save your analysis + get weekly dividend insights. Free forever.

More comparisons

ABBV vs JNJABBV vs PFEABBV vs BMYABBV vs LLYMRK vs JNJMRK vs ABBVMRK vs PFEMRK vs BMY

⚠️ Educational purposes only. Not financial advice. All projections use historical data; actual results will vary.